Redifferentiation therapy with retinoids: Therapeutic option for advanced follicular and papillary thyroid carcinoma

World Journal of Surgery

Volumn 22, Issue 6, 1998, Pages 569-574

  Simon, Dietmar ^a   Koehrle, Josef ^b   Reiners, Christoph ^b   Boerner, Anne R ^a   Schmutzler, Cornelia ^b   Mainz, K ^c   Goretzki, Peter E ^a   Roeher, Hans D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; RADIOACTIVE IODINE; THYROGLOBULIN;

ADULT; AGED; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE SEVERITY; DRUG EFFECT; DRUG UPTAKE; FEMALE; HUMAN; MALE; METASTASIS POTENTIAL; RADIOISOTOPE THERAPY; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TREATMENT PLANNING;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IODINE; MALE; MIDDLE AGED; RETINOIDS; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 0031950351     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900436     Document Type: Conference Paper

References (34)

1. Giguere, V.: Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signalling. Endocr. Rev. 15:61, 1994
2. Linney, E.: Retinoic acid receptors: transcription factors modulating gene regulation, development, and differentiation. Curr. Top. Dev. Biol. 27:309, 1992
3. Robertson, K.A., Emami, B., Collins, S.J.: Retinoic acid resistant HL-60R cells harbour a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80:1885, 1992
4. De The, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., Dejean, A.: The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyclocytic leukemia encodes a functionally altered RAR. Cell 76:333, 1992
5. Love, J.M., Gudas, L.J.: Vitamin A, differentiation, and cancer. Curr. Opin. Cell Biol. 6:825, 1994
6. Swisshelm, K., Ryan, K., Lee, X., Tsou, H.C., Peacock, M., Sager, R.: Downregulation of retinoic acid receptor beta in mammary carcinoma cell lines and its upregulation in senescing normal mammary epithelial cells. Cell Growth Differ. 5:133, 1994
7. Banker, D.E., Eisenman, R.N.: Thyroid hormone receptor can modulate retinoic acid-mediated axis formation in frog embryogenesis. Mol. Cell. Biol. 13:7540, 1993
8. Garcia-Villalba, P., Jimenez-Lara, A.M., Aranda, A.: Vitamin D interferes with transactivation of the growth hormone gene by thyroid hormone and retinoic acid. Mol. Cell. Biol. 16:318, 1996
9. Hong, W.K., Itri, L.M.: Retinoids and human cancer. In The Retinoids: Biology, Chemistry, and Medicine (2nd ed.), M.B. Sporn, A.B. Roberts, D.S. Goodman, editors. New York, Raven, 1994, pp. 597-630
10. Kiemle-Kallee, J., Porszolt, F.: Retinoide in der Onkologie. Dtsch. Med. Wochenschr. 118:390, 1993
11. Castaigne, S., Chomienne, C., Daniel, M.T., Ballerini, P., Berger, R., Fenaux, P., Degos, L.: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704, 1990
12. Huang, M.H., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhoa, L., Gu, L.J., Wang, Z.Y.: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
13. Verma, A.K.: Inhibition of both stage I and stage II skin tumor promotion by retinoic acid and the dependence of inhibition of tumor promotion on the duration of retinoic acid treatment. Cancer Res. 47:5097, 1987
14. Lippmann, S.M., Meyskens, F.L.: Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann. Intern. Med. 107:499, 1987
15. Van Herle, A.J., Agatep, M.L., Padua, D.N., III: Effects of 13-cis-retinoic acid on growth and differentiation of human follicular thyroid carcinoma cells. J. Clin. Endocrinol. Metab. 71:755, 1990
16. Schreck, R., Schnieders, F., Schmutzler, C., Köhrle, J.: Retinoids stimulate type I iodothyronine 5′-deiodinase activity in human follicular carcinoma cell lines. J. Clin. Endocrinol. Metab. 79:791, 1994
17. Jakobs, T.C., Schmutzler, C., Meissner-Weigl, J., Köhrle, J.: The promoter of the human type I 5′-deiodinase gene: mapping of the transcription start site and identification of a DR+4 thyroid hormone responsive element. Eur. J. Biochem. (in press, 1998)
18. Bassi, V., Vitale, M., Feliciello, A., De Riu, S., Rossi, G., Fenzi, G.: Retinoc acid induces intercellular adhesion molecule-1 hyperexpression in human thyroid carcinoma cell lines. J. Clin. Endocrinol. Metab. 80:1129, 1995
19. Del Senno, L., Rossi, R., Franceschetti, P., Degli Uberti, E.C.: Expression of all-trans-retinoic acid receptor RNA in human thyroid cells. Biochem. Mol. Biol. Int. 33:1107, 1994
20. Schmutzler, C., Brtko, J., Bienert, K., Köhrle, J.: Effects of retinoids and role of retinoic acid receptors in human thyroid carcinomas and cell lines derives therefrom. Exp. Clin. Endocrinol. Diab. 104(Suppl. 49):16, 1996
21. Schmutzler, C., Brtko, J., Meissner, J., Feket, E.E., Köhrle, J.: The retinoic acid receptor equipment of thyroid carcinoma cell lines and tissues. J. Endocrinol. Invest. 19(Suppl.):50, 1996
22. Goretzki, P.E., Simon, D., Frilling, A., Witte, J., Reiners, C., Grussendorf, M., Horster, F.A., Röher, H.D.: Surgical reintervention for differentiated thyroid carcinoma. Br. J. Surg. 80:1009, 1994
23. Derwahl, M., Kuemmel, M., Goretzki, P., Schatz, H., Broecker, M.: Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP. Biochem. Biophys. Res. Commun. 191:1131, 1993
24. Brönnegard, M., Törring, O., Böös, J., Sylven, C., Marcus, C., Wallin, G.: Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic and neoplastic human thyroid tissue. J. Clin. Endocrinol. Metab. 79:384, 1994
25. Köhrle, J., Oertel, M., Hoang-Vu, C, Schnieders, F., Brabant, G.: Type I 5′-deiodinase a marker for differentiated thyroid carcinoma? Exp. Clin. Endocrinol. 101:60, 1993
26. Lemaitre, M., Bauguet-Mahieu, L.: Nuclear thyroid hormone receptors in human cancer tissues. Anticancer Res. 6:695, 1986
27. Lopez-Barahona, M., Fialka, I., Gonzalez-Sancho, J.M., Asuncion, M., Gonzalez, M., Iglesias, T., Bernal, J., Beng, H., Munoz, A.: Thyroid hormone regulates stromelysin expression, protease secretion, and the morphogenetic potential of normal polarized mammary epithelial cells. EMBO J. 14:1145, 1995
28. Oppenheimer, J.H., Schwartz, H.L., Mariash, C.N., Kinlaw, W.B., Wong, N.C.W., Freake, H.C.: Advances in our understanding of thyroid hormone action at the cellular level. Endocr. Rev. 8:288, 1987
29. Weinberger, C., Thompson, C.C., Ong, E.S., Lebo, R., Gruol, D.J., Evans, R.M.: The c-erb-A gene encodes a thyroid hormone receptor. Nature 324:641, 1986
30. Miyoshi, Y., Nakamura, H., Tagami, T., Sasaki, S., Nakao, K.: 3,5,3′-Triiodothyronine stimulates retinoic acid-induced differentiation in HL-60 cells. Mol. Cell. Endocrinol. 103:119, 1994
31. Moghal, N., Neel, B.: Evidence for impaired retinoic acid receptors-thyroid hormone receptor AF-2 cofactor activity in human lung cancer. Mol. Cell. Biol. 15:3945, 1995
32. Wei, L.L., Hui, E.K., Wie, J.S., Yung, B.Y.: Alkaline phosphatase activity during the differentiation of the human promyelocytic leukemia cell line HL-60. Biochem. Biophys. Res. Commun. 182:487, 1992
33. Simon, D., Köhrle, J., Schmutzler, C, Mainz, K., Reiners, C., Röher, H.D.: Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: basics and first clinical results. Exp. Clin. Endocrinol. Diab. 104(Suppl. 4):13, 1996
34. Ledger, G.A., Mullan, B.P., O'Connor, M.K., Dunn, W., Gormann, C.A., Hay, I.D., Khosla, S.: Pilot study on the use of 13-cis retinoic acid (isotretinoin) as an adjunct to radioiodine therapy of metastatic thyroid cancer. Presented at the 76th Annual Meeting of the Endocrine Society, Program and Abstracts, 1994, p. 417